Another Player in Advanced Bladder Cancer

(MedPage Today) -- The FDA expanded indications for sacituzumab govitecan-hziy (Trodelvy) with an accelerated approval for previously treated advanced bladder cancer.The conditional approval pertains to patients with locally advanced or metastatic...